Theragnostic use of radiolabelled dota-peptides in meningioma: From clinical demand to future applications

R. Laudicella, D. Albano, S. Annunziata, D. Calabrò, G. Argiroffi, E. Abenavoli, F. Linguanti, A. Vento, A. Bruno, P. Alongi, M. Bauckneht

Research output: Contribution to journalArticle

Original languageEnglish
Article numberE1412
JournalCancers
Volume11
Issue number10
DOIs
Publication statusPublished - 2019

Cite this

Laudicella, R., Albano, D., Annunziata, S., Calabrò, D., Argiroffi, G., Abenavoli, E., Linguanti, F., Vento, A., Bruno, A., Alongi, P., & Bauckneht, M. (2019). Theragnostic use of radiolabelled dota-peptides in meningioma: From clinical demand to future applications. Cancers, 11(10), [E1412]. https://doi.org/10.3390/cancers11101412